Table 1 Baseline characteristics of patients included in the study.
Characteristics | Patients without HCC (n = 287) | Patients with HCC (n = 349) | P |
|---|---|---|---|
Age, years | 51.1 ± 10.0 | 55.4 ± 6.8 | < 0.001 |
Female sex, n (%) | 102 (35.5) | 65 (18.6) | < 0.001 |
Underlying liver disease, n (%) | < 0.001 | ||
Alcoholic | 98 (34.1) | 26 (7.4) | |
Hepatitis B | 114 (39.7) | 276 (79.1) | |
Hepatitis C | 13 (4.5) | 31 (8.9) | |
Biliary | 18 (6.3) | 0 | |
Others | 44 (15.3) | 16 (4.6) | |
MELD Na score | 22.8 ± 7.7 | 16.4 ± 6.9 | < 0.001 |
Body mass index, kg/m2 | 24.0 ± 3.2 | 24.2 ± 3.1 | 0.396 |
Deceased donor, n (%) | 115 (40.1) | 88 (25.2) | < 0.001 |
Donor age, years | 38.5 ± 13.8 | 35.2 ± 12.8 | 0.002 |
Donor female sex, n (%) | 106 (36.9) | 128 (36.7) | 0.947 |
Donor graft steatosis | |||
Macrosteatosis, % | 5 (0–5) | 1 (0–5) | 0.257 |
Microsteatosis, % | 5 (0–5) | 2 (0–5) | 0.419 |
Cold ischemia time, min | |||
Living donor | 150 (120–170) | 135 (110–170) | 0.11 |
Deceased donor | 420 (345–498) | 390 (326–496) | 0.515 |
Warm ischemia time, min | |||
Living donor | 57 (47–69) | 60 (46–72) | 0.596 |
Deceased donor | 44 (38–50) | 45 (40–55) | 0.135 |
